G-CSF Priming of Haploidentical Bone Marrow: Effects on Cell Yield, Collection Efficiency, and Tolerogenic Graft...

Area of Science:

• Hematology
• Immunology
• Transplantation

Background:

• Allogeneic hematopoietic stem cell transplantation (HSCT) from haploidentical donors is crucial for patients lacking matched donors.
• Peripheral blood stem cells are often preferred over bone marrow for faster engraftment and better survival, despite higher graft-versus-host disease (GVHD) rates.
• Limited research exists on granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared to G-CSF-primed peripheral blood stem cells.

Purpose of the Study:

• To investigate the impact of G-CSF priming on bone marrow graft collection efficiency and composition in haploidentical HSCT.
• To explore the potential of G-CSF priming to mitigate GVHD risk while preserving engraftment efficacy.

Main Methods:

• An ambispective study involving retrospective and prospective data collection from 61 patients undergoing haploidentical bone marrow HSCT.
• Analysis of hospital records for donor/recipient demographics, transplant details, and outcomes.
• Evaluation of graft composition and collection times from G-CSF-primed (n=17) and non-primed (n=9) donors.

Main Results:

• G-CSF priming significantly improved bone marrow collection efficiency.
• Priming altered graft composition, notably increasing regulatory T-cell and dendritic cell content.
• These changes suggest a shift towards a tolerogenic immune profile, potentially reducing GVHD risk.
• Engraftment efficacy was maintained alongside the observed immunological changes.

Conclusions:

• G-CSF priming of bone marrow grafts can enhance collection efficiency and modify graft composition to potentially reduce GVHD risk in haploidentical HSCT.
• The study's retrospective design and lack of a control group limit definitive causal conclusions.
• Further prospective research is warranted to validate these findings, optimize priming protocols, and assess applicability across different donor types and conditioning regimens.